First in Human Study of KO-539 in Relapsed or Refractory Acute Myeloid Leukemia

Condition:   Advanced Malignant Neoplasm Intervention:   Drug: KO-539 Sponsor:   Kura Oncology, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials